"Carboxypeptidase B2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A carboxypeptidase that removes C-terminal lysine or arginine from peptides and proteins. Carboxypeptidase B2 (CPB2) is released into the circulation as a proenzyme which is activated by the THROMBIN-THROMBOMODULIN complex. Activated CPB2 is involved in modulating a variety of processes by cleaving and inactivating various circulating proteins and peptides that are its substrates including FIBRIN; KININS; and ANAPHYLATOXINS.
| Descriptor ID |
D025901
|
| MeSH Number(s) |
D08.811.277.656.350.245.125 D08.811.277.656.350.555.225 D08.811.277.656.675.555.225 D08.811.277.656.837.092
|
| Concept/Terms |
Carboxypeptidase B2- Carboxypeptidase B2
- Arginine Carboxypeptidase
- Carboxypeptidase R
- Thrombin-Activatable Fibrinolysis Inhibitor
- Thrombin Activatable Fibrinolysis Inhibitor
- Thrombin-Activatable Fibrinolysis Inhibitor (TAFI)
- Carboxypeptidase B2, Plasma
- Plasma Carboxypeptidase B2
- Carboxypeptidase U
|
Below are MeSH descriptors whose meaning is more general than "Carboxypeptidase B2".
Below are MeSH descriptors whose meaning is more specific than "Carboxypeptidase B2".
This graph shows the total number of publications written about "Carboxypeptidase B2" by people in this website by year, and whether "Carboxypeptidase B2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2017 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Carboxypeptidase B2" by people in Profiles.
-
Overexpression of TAFI promotes epithelial mesenchymal transition in endometriosis. Eur Rev Med Pharmacol Sci. 2017 12; 21(24):5527-5533.
-
Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint Arthroplasty. Clin Appl Thromb Hemost. 2017 Nov; 23(8):967-972.
-
Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation. Blood Coagul Fibrinolysis. 2008 Mar; 19(2):135-41.